: HIV infection is associated with increased risk to lower Background respiratory tract infections (LRTI). However, the impact of HIV infection on immune cell populations in the lung is not well defined. We sought to comprehensively characterise the impact of HIV infection on immune cell populations in the lung.
, which account for 75-98% of lung complications in antiretroviral therapy (ART)-naïve HIVinfected adults worldwide 3, 4 . Predisposition to LRTIs is largely attributed to HIV-induced impairment of lung immunity, including reduced frequency of respiratory antigen-specific alveolar CD4 + T cells [5] [6] [7] as well as impaired alveolar macrophage function 5, 8 . HIV infection is also associated with CD8 + T cell alveolitis, a condition characterized by the influx of HIV-specific CD8 + T cells into the lung 9, 10 . While these immune cell perturbations partly underlie propensity for LRTIs in HIV-infected individuals, the impact of HIV infection on the composition and functions of other immune cell populations in the lung is not well defined.
Several studies have reported alterations in the proportions and functions of different immune cell populations in peripheral blood in HIV-infected individuals [11] [12] [13] [14] . We, therefore, undertook a comprehensive characterisation of the impact of HIV infection on immune cell populations in the lung. We obtained paired bronchoalveolar lavage (BAL) fluid and peripheral blood from HIV-uninfected and asymptomatic HIVinfected, antiretroviral therapy (ART)-naïve Malawian adults. We analysed and compared the proportions and numbers of CD4 + and CD8 + T cells, B cells, NK cell subsets, γδ T cells, monocytes, dendritic cell subsets, neutrophils and alveolar macrophages in samples from HIV-infected and uninfected individuals.
Methods

Study participants
The study was conducted at the Queen Elizabeth Central Hospital, a large teaching hospital in Blantyre, Malawi. Participants were recruited from the hospital's voluntary counselling and testing (VCT) and ART clinics. They were adults aged ≥18yrs comprising healthy HIV-1-uninfected and asymptomatic HIV-1-infected volunteers with no clinical evidence of active disease and willing to undergo bronchoscopy and BAL for research purposes 18 . Clinical diagnosis and radiographic examination were used to exclude individuals with active disease, including TB, from the study. No latent TB tests were carried out on the participants. The study participants were recruited from the same catchment area, with relatively similar environmental exposures. HIV testing was performed on whole blood using two commercial point-of-care rapid HIV test kits, Determine HIV 1/2 kit (Abbott Diagnostic Division) and Unigold HIV 1/2 kit (Trinity Biotech Inc.). A participant was considered HIVuninfected if the test was negative by both kits or HIV-infected if the test was positive by both kits. If Determine and Unigold results were discordant, a third rapid test using Bioline HIV 1/2 kit (Standard Diagnostics Inc.) was performed to resolve the discordance. No baseline viral loads were done on the HIVinfected individuals. However, none of the participants were on ART at the time of recruitment to the study, but all initiated ART after sample collection according to the 'test and treat' Malawi national treatment guidelines. Exclusion criteria for the study were: current or history of smoking, use of immunosuppressive drugs, severe anaemia (Hb<8g/dl) and known or suspected pregnancy. The research ethics committee of Malawi College of Medicine approved the study under approval number P.03/16/1907 and all participants provided written informed consent.
Sample collection and experimental procedures
Bronchoscopy and BAL were performed on all participants as previously described 5, 6, 8 . Briefly, we used Instillagel to lubricate the nostrils and 2% lignocaine for vocal cords and the airways. A fiber-optic bronchoscope (Olympus, UK) was passed to the level of a sub-segmental bronchus of the right middle lobe and four 50 ml aliquots of sterile normal saline at 37°C instilled and removed using gentle hand suction. A typical BAL return from a 200ml instill is 100-140ml. The aspirated bronchoalveolar lavage fluid was placed into 50ml falcon tubes and transferred immediately to the laboratory for processing within 30 min. The fluid was filtered using sterile gauze and centrifuged at 500g for 10min. The supernatant was removed, the cell pellet was resuspended and washed with PBS by spinning in a centrifuge at 500g for 10min. The supernatant was removed and discarded while the cell pellet was resuspended in complete media. Upon microscopic examination, the cell pellet contained <5% bronchial epithelial cells or squamous cells. Due to time taken from BAL isolation and sample acquisition, there is a potential for changes in cell viability, especially neutrophils, however, the a standardised study protocol was applied to both study groups to minimise the time from isolation to acquisition. Peripheral blood was also obtained from study participants for full blood count (FBC) and peripheral blood mononuclear cell (PBMC) isolation using density gradient centrifugation. Cell counts in BAL cells and PBMCs isolated from each sample were performed using a haemocytometer.
Immunophenotyping Whole BAL cells (1 × 10 6 cells) and PBMCs (1 × 10 6 cells) were stained with predetermined optimal concentration of fluorochrome-conjugated monoclonal antibodies against human cell surface proteins. Two separate antibody panels targeting lymphocytic and myeloid cells were used. The lymphocyte
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Statistical analysis
Statistical analyses and graphical presentation were performed using GraphPad Prism 5 (GraphPad Software, USA). We used FlowJo v10 software (Treestar, USA) to analyse flow cytometry data. The numbers of cell subsets in BAL fluid were estimated by calculating the proportion of a particular subset relative to the total number (1 × 10 6 cells) of stained cells. The cell count was first calculated as number of cells relative to the BAL volume return of each individual, and this was then standardised to cells per 100ml BAL fluid as previously published 5, 6 . In PBMCs, the absolute numbers were obtained by calculating the proportion of a particular subset relative to the full blood count (FBC) data, specifically, lymphocyte and monocytes counts. Data were analysed using Mann Whitney U test. Results are given as median and interquartile range (IQR). Differences were considered statistically significant when p<0.05. Table 1 . Not all experimental assays were performed on all study participants.
Results
Study participants and samples
CD8
+ T cells, B cells and γδ T cells contribute to HIVassociated lymphocyte infiltration in the alveolar space We investigated the impact of HIV infection on the proportion and numbers of lymphocyte populations using flow cytometry. The gating strategy is illustrated in Figure 1 . We found that the proportions and numbers of lymphocytes in BAL fluid were higher in HIV-infected adults compared to HIV-uninfected (median 20.8% vs. 8.5%, p=0.0004 and median 1 × 10 7 vs. 2.7 × 10 6 cells/100ml of BAL fluid, p=0.0005, respectively) ( Figure 2A and 2B). We next determined the cell subsets that were responsible for the increased frequency of lymphocytes in the alveoli. We found that the proportions and numbers of CD8 + T cells (median, 68% vs. 32%, p<0.0001 and median 7 × 10 6 vs. 7 × 10 5 /100ml of BAL fluid, p<0.0001, respectively) and B cells (median 1.8% vs. 0.8%, p=0.0014 and median 7 × 10 4 vs. 1 × 10 4 /100ml of BAL fluid, p<0.0001, respectively) in BAL fluid were higher in HIV-infected adults compared to HIV-uninfected controls ( Figure 2C-2F) . The proportion and numbers of γδ T cells were also higher in BAL fluid from HIVinfected adults compared HIV-uninfected controls (median 1.4% vs. 0.8%, p=0.036 and median 1 × 10 5 vs. 2 × 10 4 /100ml of BAL fluid, p=0.0002, respectively) ( Figure 3A and 3B ).
In contrast, the proportions of CD4 + T cells and NK cells in BAL fluid were lower in HIV-infected adults compared to HIV-uninfected controls (CD4 + T cell, median 2% vs. 4%, p<0.0001; NK cells, median 1% vs. 2%, p<0.0001) ( Figure 2C and Figure 3C ). However, the numbers showed no difference in CD4 + T cells (median 1.1 × 10 6 vs. 1.0 × 10 6 /100 ml of BAL fluid, p=0.7065) and NK cells (median 5.4 × 10 4 vs. 4.9 × 10 4 /100ml of BAL fluid, p=0.8911) between HIV-infected adults and HIV-uninfected controls ( Figure 2D and Figure 3D Differential impact of HIV infection on lymphocyte subsets in the alveolar and blood compartments We then investigated the similarities and differences of HIVassociated changes in cell composition between BAL fluid and peripheral blood. In agreement with BAL fluid, the proportions of CD8 + T cells in peripheral blood were higher in HIV infected adults compared to HIV-uninfected controls (Median 47% vs. 24%, p<0.0001) (Supplementary Figure 1) . The proportions of CD4 + T cells in peripheral blood were lower in HIV-infected adults compared to HIV-uninfected controls (Median 20% vs. 46%, p<0.0001) (Supplementary Figure 1) . In contrast with BAL fluid, the proportion of B cells in peripheral blood was lower in HIVinfected adults compared to HIV-uninfected controls (Median 5.8% vs. 9.4%, p=0.0472) (Supplementary Figure 1) . The proportion of CD3 + CD56
+ NK T cells in peripheral blood was lower in HIV-infected adults compared to HIV-uninfected controls (Median 0.03% vs. 0.09%, p=0.0386) (Supplementary Figure 1) . The proportion of CD8 γδ T cells in peripheral blood was higher in HIV-infected adults compared to HIV-uninfected controls (Median 1.9% vs. 0.76%, p=0.0229) (Supplementary Figure 1) . The findings show that HIV infection differentially impacts lymphocyte populations in the alveolar space and peripheral blood compartments.
Differential impact of HIV infection on monocyte subsets in the alveolar and blood compartments Next, we investigated the impact of HIV infection on the monocyte population in BAL fluid compared to peripheral blood. The gating strategy is illustrated in Figure 4 . First we determined the composition of the monocyte cell population in BAL fluid in comparison to peripheral blood. (Figure 5B and 5D ).
Second, we compared the proportions and numbers of monocyte population in BAL fluid and peripheral blood between HIVinfected adults and HIV-uninfected controls. In BAL fluid, we found that the proportion and numbers of CD14 80% vs. 64%, p=0.0011) but the numbers were similar between the two groups (median 6.0 × 10 5 vs. 7.7 × 10 5 cells/100ml of BAL fluid, p=0.8628) ( Figure 5C and 5E + non classical monocytes (median 30 vs. 10 cells/1000 mm 3 , p=0.0316) were higher in HIV-infected adults compared to HIV-uninfected controls ( Figure 5F ). These findings underscore differences in the composition and the impact of HIV infection on immune cells in the lung and systemic compartments.
Altered proportions of alveolar macrophages and dendritic cell populations in HIV-infected adults Lastly, we investigated the impact of HIV on alveolar macrophages (AM), neutrophils and dendritic cell populations in BAL fluid. We found that the proportions of alveolar macrophages and myeloid dendritic cells were lower in HIV infected adults compared to HIV-uninfected controls (AM, median 73% vs. 80%, p=0.0109; mDC, median 0.6% vs. 0.9%, p=0.0036) ( Figure 6A and 6C). The proportion of neutrophils and plasmacytoid dendritic cells was similar between HIV-infected adults and HIV-uninfected controls (neutrophils, median 0.34% vs. 0.14%, p=0.0789; pDC, median 0.04% vs. 0.05%, p=0.1947) ( Figure 6A  and 6C similar between the HIV-infected adults and HIV-uninfected controls ( Figure 6B and 6D ). Taken together, the findings show that chronic HIV-infection is associated with a disruption in the homeostatic proportions of alveolar macrophage and dendritic cell populations.
Discussion
We report the broad impact of HIV infection on immune cell populations in the alveolar space beyond the well-characterised CD8 + T cell alveolitis observed in previous studies 5, 6, 9, 10 . We show that in addition to CD8 + T cells, B cells and γδ T cells are increased, while classical monocytes are decreased in BAL fluid from ART-naïve HIV-infected adults compared to HIV-uninfected individuals. We further show generalised disruption in the proportions of immune cell subsets including alveolar macrophages, CD4 + T cells, myeloid dendritic cells, intermediate monocytes and NK cells in BAL fluid of asymptomatic chronic HIV-infected adults.
Although HIV-infection was associated with accumulation of B cells and γδ T cells in BAL fluid, their contribution to pulmonary immunity during chronic HIV infection is incompletely understood. However, previous studies have reported HIV-associated impairment of function of these two cell subsets in peripheral blood [19] [20] [21] . Consistent with what has been observed in the systemic circulation, hyperglobulinemia has been reported in BAL fluid of HIV-infected adults 22, 23 , but the antibodies have impaired opsonic function 24 . It is plausible that the HIV-associated increase in B cells in the lung results in increased antibody production and BAL fluid hyperglobulinemia. Furthermore, the increase in γδ T cells that we found in the present study supports the findings of Agostini et. al. 25 , who showed that HIV-infected individuals with CD8 + T cell alveolitis had increased γδ T cells in BAL fluid, which were predominantly of the Vδ2 subset. However, HIV infection was also associated with anergic γδ T cells that were characterised by their substantially deficient response to phosphoantigens [26] [27] [28] . Taken together, the findings of previous studies lead us to postulate that despite the increase in numbers, lung B cells and γδ T cells from HIV-infected individuals have impaired function as their blood counterparts. 8, 37 . The abundance of intermediate monocytes and AM in BAL fluid increases potential cellular targets for HIV. Our findings that AM are preserved during chronic HIV infection, may partly be attributed to the long life span of these cells 38, 39 , as well as their resistance to the cytopathic effects of HIV 40, 41 . In contrast, we observed a depletion in classical monocytes in BAL fluid from HIVinfected individuals. The mechanism for the selective depletion of classical monocytes is unclear, but might involve HIV-induced apoptosis 42 or loss/downregulation of surface CD14 43 . In steady state, alveolar macrophages originate from erythro-myeloid progenitors (EMPs), while monocytes originate from haematopoietic stem cells (HSCs) 44 , hence the differential impact of HIV on these subsets might be due to the distinct nature of their source of origin. On the other hand, during an inflammatory state, classical monocytes are thought to differentiate into lung macrophages and contribute to clearance of invading pathogens 45 . Presence of a wide array of HIV-permissive cells in the lung, including recruited and resident cells, could contribute to maintenance of local viral production and subsequent disruption of immune cell populations and homeostasis in this compartment.
HIV infection is associated with massive depletion of mucosal
A potential limitation of the study is that the numbers of BAL cell subsets are extremely difficult to measure with a very high degree of accuracy due to the variations in the dilution factor of epithelial lining fluid and differences in BAL fluid volume return. However, using a method utilised in previous studies 5, 6 , we calculated numbers of cell subsets using the BAL cell count obtained from a haemocytometer combined with proportions obtained by immunophenotyping. We have confidence in the reliability of this method to measure the numbers for the other cell subsets, as we have replicated the observation that the absolute number of CD8 + T cells is higher in HIV-infected adults compared with HIV-uninfected individuals 5, 6, 9, 10 . Furthermore, using data from our previous work that focused on measuring cytokines in BAL fluid, we found no statistically significant difference in concentration of urea in BAL fluid between HIV-infected adults compared to HIV-uninfected individuals, suggesting that permeability of the alveolar space might not be different in the two groups (unpublished).
In conclusion, our findings show that HIV infection is associated with broad alteration of immune cell populations in the lung. Disruption in immune homeostasis has been shown to lead to increased susceptibility to both infectious and non-infectious diseases. The broad alteration of immune cell populations in the lung in part explain the propensity to LRTI in HIV-infected individuals. However, the degree to which successful antiretroviral therapy restores the composition of immune cells in the lung warrants further investigation.
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I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. 
8.
More details regarding whether there was appropriate matching of cases and controls should be provided. It is unclear whether co-morbidities and environmental exposures that may impact lung immune responses were well matched across arms. For example, were respiratory diseases or symptoms present in any participants? Was a history of environmental exposures taken (eg. indoor smoke, occupational)? Were participants asked about previous TB, current TB symptoms and was any TB diagnostic work-up undertaken in those with symptoms? Was there a chest X-ray done in participants? Was any testing for TB infection ("latent TB") undertaken?
The term alveolitis is used in the title. "Alveolitis" suggests a clinical syndrome characterized by lung inflammation focused on the alveoli (as is the case with CD8+ alveolitis in HIV-infected patients -this manifests with a clinical syndrome). The authors have described increased numbers of certain immune cell types in the alveoli. I do not think this represents alveolitis and suggest changing this term in the title.
In the abstract it is stated that HIV "does not lead to massive depletion of alveolar CD4+ T cells". This is true for the participants studied but most had CD4 count in blood > 200 thus this statement should be qualified by recognising this may not apply to patients with severe CD4 depletion in blood.
In the Methods, the delay between taking the BAL sample and processing should be described. This may affect cell viability, especially neutrophils.
On page 3 for this statement: "In PBMCs, the absolute numbers were obtained by calculating the proportion of a particular subset relative to the full blood count (FBC) data." Suggest providing details about which cell populations from the FBC data were used for denominators in calculating cell numbers from the FACS data. ." The statement I underlined even in those with depleted peripheral blood CD4+ T cells should be justified by data presented. Was a stratified analysis of those with CD4<200 or <350 conducted?
The authors acknowledge that the accuracy of measurement of cell numbers in BAL may be inaccurate because of variations in the dilution factor of epithelial lining fluid and differences in BAL fluid volume return. They do not provide details on any methods they used to standardise this measurement across participants. For example in the BAL sampling technique or in standardising to a constituent of ELF. Suggest discuss this in more detail.
Additional comments from my colleague Dr Muki Shey:
General comments I was not certain whether clinically the presence of immune cells in the lungs of (HIV-infected) individuals I was not certain whether clinically the presence of immune cells in the lungs of (HIV-infected) individuals constitute alveolitis, otherwise definition and contextualization was missing.
There is no mention of TB infection in the participants or location where participants were recruited. Was there any screening for TB? Some more discussion is necessary about the differences between cell numbers and proportions in BAL and Blood.
Specific comments
Figure 1 HLA-DR antibody is mentioned in methods section but not shown either as a marker of activation or identification of myeloid cells. HLA-DR is an important marker of myeloid cell identification, especially in whole blood. Mwale and co-workers examine the cellular composition of BAL asymptomatic HIV-positive Malawians. They show increased numbers of CD8 T-cells, B-cells and gd T-cells, while also identifying a reduction in classical monocytes in HIV which resulted in an increased proportion but not absolute number of intermediate monocytes. The data is important and adds a significant contribution to the literature, in particular through providing clinically relevant samples in HIV in patients naïve to ART. While the data makes a valuable contribution to the literature some areas of further detail would be informative.
Background demographic data shows the control group are well matched in terms of age and gender. More details on the HIV-positive group are required. What steps were taken to exclude TB. Is there any data on baseline CXR or TB screening or is the assumption that patients were negative purely based on lack of symptoms? Is there any data on baseline HIV viral load? Some further methodological details would aid interpretation. While the differences in proportions of cell subsets are clear interpretation of absolute numbers requires evidence that volumes of instillation and BAL recovery are similar. Can the authors report their standard methodology involved instillation of 200 mls in four aliquots, into the right middle lobe, or whatever? Have they specific data on the volume recovered ad its variability. Can they confirm there were low (<5%) numbers of bronchial epithelial cells or squamous cells?
Although the focus is analysis of cellular components have they any information on the permeability of the alveolar space in the two groups through measurement of albumin or a related 3.
4.
5.
6.
Although the focus is analysis of cellular components have they any information on the permeability of the alveolar space in the two groups through measurement of albumin or a related marker? The authors appropriately remark in the discussion that these considerations limit interpretation of absolute numbers so this comment is meant only to provide detail not as a significant criticism.
The absolute number of monocytes in BAL should also be reported. In the abstract, the primary finding is presented as an increase in the proportion of intermediate monocytes in HIV BAL but in reality, the main finding appears to be a reduction in absolute number of classical monocytes which results in a relative rather than absolute increase in intermediate monocytes in HIV. Subsets of intermediate monocytes may also be defined by HLA-DR and the authors appear to have also used antibodies against HLA-DR. Did they find any differences in intermediate subsets by HLA-DR in their HIV positive population?
While reductions in non-classical monocytes are described by many groups the magnitude of the reduction in numbers of non-classical monocytes in the BAL is a little surprising since these cells are thought to be a source of alveolar macrophages. The authors suggest they can detect very few classical cells in BAL in contrast to the blood. Some more discussion of this point seems needed. Have the authors any data with alternative markers e.g. CCR2, CX3CR1 to confirm such low numbers? Or may they be missing some non-classical monocytes? This finding should be developed further and discussed a little further and related to other BAL-specific lung data.
In the discussion the authors highlight the different origins of monocytes and lung macrophages but some qualification of the differences in origin of lung macrophages in inflammatory settings and the potential for classical monocytes to contribute to lung macrophage numbers in inflammation may be pertinent.
In Figure 5D the HIV + dot has been labelled HIV -and needs to be altered. Thank you for the helpful comments. We have revised the manuscript to incorporate your suggestions.
Specifically, provided more details in the methodology section and added more information in the discussion section.
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